about
Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's DiseaseSafety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue SyndromeSPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive DisorderEvaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHDEfficacy and Safety of SPD503 in Combination With PsychostimulantsEffectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity DisorderSmoking Cessation Study In Healthy Adolescent SmokersEfficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric (7-17 Years) With Major Depressive Disorder
P6153
Q61921280-46660DE6-64AE-4938-B48A-12FE3639045DQ61936053-B3B1B574-92EF-4F4A-96B6-9802BB108C98Q61938731-24D164AA-E534-4E56-B8B1-94F5A3453DF4Q61955657-FB5C80D3-9420-47A2-9838-512A0AFC513BQ61967900-951FC73C-0E63-43C6-A497-1F03A76DA8C4Q61980350-81D8E6D9-41DB-422D-A49D-0B1D969572F5Q63063555-6C28E22E-BACA-4258-B114-B783E9D72E68Q63319394-D378EF78-E4E8-47D7-BF26-F0959F1672D3Q63338927-7010AC5C-DB6D-43A4-9974-D68003E4CDA3Q63397616-3B1A2F6D-02F0-4594-A8EB-B71F796BB157
P6153
description
healthcare organization in Rochester Hills, United States
@en
name
Rochester Center for Behavioral Medicine
@en
type
label
Rochester Center for Behavioral Medicine
@en
altLabel
RCBM
@en
prefLabel
Rochester Center for Behavioral Medicine
@en
P131
P2427
grid.490457.b
P625
Point (-83.152242 42.675848)